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5Theoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, New MexicoABSTRACT Proteins in cell signaling networks tend to interact promiscuously through low-affinity interactions. Consequently,
evaluating the physiological importance of mapped interactions can be difficult. Attempts to do so have tended to focus on single,
measurable physicochemical factors, such as affinity or abundance. For example, interaction importance has been assessed on
the basis of the relative affinities of binding partners for a protein of interest, such as a receptor. However, multiple factors can be
expected to simultaneously influence the recruitment of proteins to a receptor (and the potential of these proteins to contribute to
receptor signaling), including affinity, abundance, and competition, which is a network property. Here, we demonstrate that mea-
surements of protein copy numbers and binding affinities can be integrated within the framework of a mechanistic, computational
model that accounts for mass action and competition. We use cell line-specific models to rank the relative importance of protein-
protein interactions in the epidermal growth factor receptor (EGFR) signaling network for 11 different cell lines. Each model
accounts for experimentally characterized interactions of six autophosphorylation sites in EGFR with proteins containing a
Src homology 2 and/or phosphotyrosine-binding domain. We measure importance as the predicted maximal extent of recruit-
ment of a protein to EGFR following ligand-stimulated activation of EGFR signaling. We find that interactions ranked highly
by this metric include experimentally detected interactions. Proteins with high importance rank in multiple cell lines include
proteins with recognized, well-characterized roles in EGFR signaling, such as GRB2 and SHC1, as well as a protein with a
less well-defined role, YES1. Our results reveal potential cell line-specific differences in recruitment.INTRODUCTIONSignaling proteins operate within large, complex networks
(1,2). One aspect of network complexity is that signaling
proteins tend to participate in multiple interactions, with
overlapping specificities (3,4). (This molecular promiscuity
and polyspecificity is a general feature of proteins.) For
example, in a recent study, Jones and co-workers (5) charac-
terized a total of 1405 specific interactions between phos-
photyrosine-containing peptides of the four members of
the ErbB family of receptor tyrosine kinases (RTKs) and a
collection of human Src homology 2 (SH2) and phosphotyr-
osine-binding (PTB) domains. As is typical of interactions
detected and characterized in high-throughput experiments,
many of these interactions have affinities that can be consid-
ered low, and most do not have known or clear physiological
relevance.
In phosphotyrosine signaling (6), although different SH2/
PTB domains do recognize a given phosphotyrosine-con-
taining peptide with different affinities (7), affinity differ-
ences alone are insufficient to confer a high degree ofSubmitted July 10, 2014, and accepted for publication February 24, 2015.
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tions (8). It has been speculated that factors beyond affinity,
such as compartmentalization, are responsible for confer-
ring specificity (9). However, these possible determinants
of specificity are poorly characterized. Moreover, the spec-
ificity requirements of cellular information processing are
somewhat unclear. It may be that numerous, low-affinity in-
teractions are not only tolerated but are essential for certain
information processing functions. Jones (10) has argued that
low-affinity interactions are likely to have physiological sig-
nificance, which has been overlooked mainly because of the
difficulty of detecting and studying such interactions.
In any case, for proteins with well-characterized roles in a
cell signaling network, it is rare for all of their known inter-
actions to receive attention in an experimental or modeling
study. Indeed, there is a stark contrast between the interac-
tion networks considered in typical pathway diagrams (for
an example of a large diagram, see (11)) or in typical math-
ematical/computational models (12) and the much larger
interaction networks defined by databases that collect infor-
mation reported in the primary literature, such as HPRD
(13); databases that collect predicted interactions, such as
PrePPI (14,15); or databases that collect interactions de-
tected in high-throughput screens, such as BioGRID (16).http://dx.doi.org/10.1016/j.bpj.2015.02.030
1820 Stites et al.Thus, most interactions are somewhat enigmatic and we
lack a sound understanding of the functional consequences
of molecular promiscuity and polyspecificity, especially at
the systems level.
With the emergence of reliable methods for elucidating
key structural details of protein-protein interactions (e.g.,
the interfaces or the parts/sites of proteins responsible for
interactions) (17,18) and techniques that provide compre-
hensive and high-precision measurements of affinities for
site-specific interactions (5,19,20), as well as absolute pro-
tein copy numbers (21,22), we now have an opportunity to
use this information to evaluate interaction networks in
toto and begin to quantitatively assess the relative impor-
tance of detected protein-protein interactions. For example,
through application of the law of mass action, we can
consider how affinity and the abundances of interaction part-
ners combine to influence extent of interaction. We can also
consider how extent of interaction is affected by competi-
tion, which is a network property that can vary with cell
type or changes of the (intra)cellular milieu. However, at-
tempts to interpret interactomic/proteomic data have been
limited (23). For example, Jones et al. (24) used affinities
alone, together with an arbitrary affinity threshold, to esti-
mate the relative promiscuities of ErbB family RTKs,
even though a small KD for an interaction is meaningless
if a protein involved in the interaction is not expressed.
Mechanistic modeling, which has been identified as having
an important role to play in analyzing cell signaling net-
works (25), may be able to aid in integrating and interpret-
ing interactomic/proteomic data sets.
Here, building on past modeling efforts and our current
quantitative understanding of epidermal growth factor
(EGF) receptor (EGFR) signaling (26–32) and using fairly
new enabling computational approaches (33–35), we
leverage multiple high-throughput proteomic data sets to
construct and analyze cell line-specific computational
models for early EGFR signaling events. These models
break new ground in that each accounts for cell line-specific
protein expression and the mapped, direct interactions be-
tween six phosphotyrosines in EGFR, which are generated
through autophosphorylation, and numerous SH2/PTB
domain-containing signaling proteins. In developing these
models, we used measurements of affinities made for site-
specific interactions (5) to constrain kinetic binding param-
eters, and we used measurements of protein abundances for
11 different cell lines (22,36) to set the cytoplasmic concen-
trations of proteins. Thus, our models account for cell
line-specific differences in protein copy numbers. (The
rate constants for phosphotyrosine-SH2/PTB domain inter-
actions are the same for all models.)
Measurements of binding affinities obtained via a high-
throughput technique and relative protein expression levels
in multiple cell lines have been used in earlier modeling
work focused on EGFR signaling (37), but in a more limited
way. For example, in this earlier work, only a few selectedBiophysical Journal 108(7) 1819–1829direct binding partners of EGFR (GRB2, SHC1, IRS1,
and an unspecified protein tyrosine phosphatase) were
considered.
We use our cell line-specific models to predict recruit-
ment of signaling proteins to EGFR. We give special atten-
tion to HeLa cells, for which copy number measurements
are available from two different studies (22,36), and HEK
293 cells. These two cell lines have been used in experi-
mental studies aimed at elucidation of EGFR binding
partners (38,39). Our simulation results indicate cell line-
specific differences in recruitment of signaling proteins to
EGFR, although there are many commonalities across cell
lines. Using our models, we measure the importance of an
interaction, or set of interactions, by the maximal predicted
extent of recruitment facilitated by the interaction(s) of in-
terest. By this metric, many of the well-characterized bind-
ing/signaling partners of EGFR, such as SHC1 and GRB2,
are identified as important in multiple cell lines. Notably,
in addition, we identify the Src-family protein tyrosine ki-
nase (SFK) YES1, which is not widely recognized as play-
ing an important role in EGFR signaling, as one of the more
important binding/signaling partners of EGFR. To evaluate
these results, we compare importance rankings derived
from the predictions of our model, which concern relative
levels of recruitment of signaling proteins to activated
EGFR, against the rankings obtained from simpler ad hoc
approaches, such as affinity-based rankings. We compare
the rankings obtained from each metric against experi-
mental measurements of association (38,39).MATERIALS AND METHODS
Model development
As described in Text S1 in the Supporting Material, we built a generic (cell
type/cell line independent) model for early EGFR signaling events that en-
compasses the following processes: ligand (EGF) binding to receptor
(EGFR); constitutive and ligand-induced receptor dimerization via recep-
tor-receptor interaction; ligand- and dimer-dependent autophosphorylation
of tyrosines in EGFR; dephosphorylation of phosphorylated tyrosine resi-
dues (when not shielded by a binding partner) through high, constitutive
phosphatase activity; endocytosis and recycling and lysosomal degradation
of internalized EGF and EGFR; and phosphotyrosine-SH2/PTB domain
interactions.
The goal of model development was to build a model capable of 1) incor-
porating cell line-specific measurements of protein abundances and mea-
surements of binding affinities for phosphotyrosine-SH2/PTB domain
interactions and 2) predicting the effects of mass action and competition
on recruitment of SH2/PTB domain-containing signaling proteins to
ligand-activated EGFR. We focused on using protein abundance measure-
ments of Mann and co-workers (22,36), which characterize 11 different
cell lines (including two separate characterizations of protein expression
in HeLa cells), and the KD measurements of Hause et al. (5). Thus, our
model omits interactions not characterized in the latter study, such as the
interaction of CBL with EGFR and the interactions of EGFR with other
ErbB receptor family members. (These interactions are not mediated by
an SH2 or PTB domain.) Moreover, our model omits interactions among
the direct binding partners of EGFR that are included in the model.
Although some of these interactions have been quantitatively characterized
Model-Guided Analysis of Proteomic Data 1821(e.g., the interaction of GRB2 with phosphorylated SHC1), we are not
aware of data that could be used to guide the estimation of binding param-
eters for all mapped interactions. An attempt to include these interactions
would entail significant complications of the model and produce uneven-
ness in scope and support (i.e., idiosyncratic inclusion and omission of
mechanistic details and varying levels of evidence for different parameters
and aspects of model structure). Although the model includes endocytosis,
because this process contributes to removal of phosphotyrosines on a fairly
fast timescale (40), we do not attempt to account for differences in signaling
from different subcellular locations (41).
The generic model is made specific for a particular cell line by parame-
terizing it using measured protein copy numbers for that cell line. The nov-
elty of the model concerns the treatment of mapped phosphotyrosine-SH2/
PTB domain interactions, which is more comprehensive than that of earlier
models. Other parts of the model are considered because these parts are
necessary to translate a ligand stimulus into phosphorylation of receptor ty-
rosines and to account for processes that reverse and eliminate receptor
phosphorylation. These parts of the model and their associated parameter
estimates were taken from the literature. Parameter settings are summarized
in Table S1 for the HeLa cell-specific model that was parameterized using
the absolute protein copy number measurements of Kulak et al. (22)Performing simulations
Software S1 consists of a collection of plain-text files that can be processed
by BioNetGen (33,42) and NFsim (35). The files with .bngl filename exten-
sions provide executable model specifications, which include parameter set-
tings, and the files with .rnf filename extensions define simulation
protocols. Simulations of EGFR signaling in HeLa cells were driven by
the file EGFR_K_HeLa.bngl, which defines a HeLa cell-specific version
of our generic model for EGFR signaling that is consistent with the copy
number measurements of Kulak et al. (22), and the file EGFR_K_HeLa.rnf,
which defines a simulation protocol. Similarly, simulations of EGFR
signaling in HeLa and HEK 293 cells based on the copy number measure-
ments of Geiger et al. (36) were driven by the files EGFR_G_HeLa.bngl,
EGFR_G_HeLa.rnf, EGFR_G_HEK293.bngl, and EGFR_G_HEK293.rnf.
Simulations were performed by using BioNetGen (33,42) to process a .bngl
file and thereby produce an XML file readable by NFsim (35). This XML
file and the appropriate corresponding .rnf file were then provided as inputs
to NFsim, which implements a particle-based kinetic Monte Carlo method
tailored for stochastic simulation of biomolecular interactions defined in
terms of rules (34). Before simulating the response to EGF addition, equil-
ibration simulations, which began at a convenient initial condition, were
performed to establish a basal steady state. In other words, we simulated
the interactions considered in a cell line-specific model in the absence of
EGF until concentrations reached their basal steady-state values. The re-
sults of a simulation run are recorded by NFsim in a plain-text file with a
.gdat filename extension. Simulation outputs produced by NFsim must be
defined; outputs are defined in the observables block of each .bngl file pro-
vided in Software S1 using the conventions of BNGL (33).
As discussed in a recent review (43), there are two broad categories of
methods available for simulating rule-based models: indirect methods and
direct methods. With an indirect method, given a rule-based model, one per-
forms a simulation via a procedure involving the following steps: 1)
network generation, in which the rules of a model are translated into a re-
action network; 2) specification of a corresponding model in a traditional
form, such as that of a coupled system of ordinary differential equations
(ODEs); and 3) simulation using a standard method available for the tradi-
tional model form found, such as a method for numerical integration of
ODEs. Indirect methods break down when the rules of a model imply a re-
action network that is very large, which is the case here. In a direct method,
the rules of a model are used as event generators in a discrete-event stochas-
tic simulation algorithm, such as that implemented in NFsim (34,35,44).
Thus, with use of a direct method, it is not necessary to find the reaction
network implied by the rules of a model.Results from 10 independent (stochastic) simulation runs were averaged to
produce smoothed time courses for calculating peak recruitment levels. In
these simulations, for reasons of efficiency, we sometimes considered only
a fraction of a whole cell, except when considering HeLa cells and the copy
numbermeasurements of Kulak et al. (22). In this case, we always considered
a whole cell. For HEK 293 cells, we considered 1% of a cell. For other cases,
we considered 0.1%of a cell. The cost of stochastic simulation increases with
the number of molecules considered; considering a reaction subvolume, thus,
decreases computational cost (at the expense of increased fluctuations). A full
cell was considered when evaluating stochasticity of recruitment.
The scope of the generic model and each cell line-specific model is
limited to six sites of EGFR autophosphorylation, which are the EGFR ty-
rosines annotated as substrates of the EGFR kinase in the UniProt entry for
EGFR (www.uniprot.org/uniprot/P00533).Ranking interactions and evaluating rankings
We investigated the value of knowing 1) measured protein copy numbers
only, 2) measured equilibrium dissociation constants only, 3) the ratios of
copy numbers and dissociation constants, and 4) simulated peak association
intensities, which are influenced by measured protein copy numbers,
measured equilibrium dissociation constants, and competition. We defined
importance metrics based on these quantities and compared rankings of
phosphotyrosine-SH2/PTB domain interactions based on each metric
against available measurements of association. We considered the associa-
tion data of Schulze et al. (38), who used phosphotyrosine-containing pep-
tides from EGFR in pulldown assays with HeLa cell lysates and a mass
spectrometry-based method for binding partner identification. We also
considered the association data of Tong et al. (39), who used antibodies
against FLAG-tagged EGFR to pull down EGFR and its binding partners
in HEK 293 cells and a mass spectrometry-based method for binding part-
ner identification. We limited our analysis to SH2/PTB domain-containing
proteins, and further limited ourselves to the list of proteins studied by
Hause et al. (5). For a protein that binds EGFR at multiple phosphotyrosines
and/or with multiple SH2/PTB domains, we considered only the minimum
equilibrium dissociation constant (KD) among the relevant phosphotyro-
sines and SH2/PTB domains. For HeLa cells, the copy number of a poten-
tial EGFR binding partner was taken to be that reported by Kulak et al. (22).
For HEK 293 cells, we used averages of the iBAQ values reported by Gei-
ger et al. (36) to set copy numbers. For simulations, we considered peak as-
sociation intensity of an EGFR binding partner to be the maximum average
number of this protein predicted to be bound to EGFR molecules over
repeated simulated time courses, each observed at 1 min intervals, starting
with initiation of EGFR signaling by EGF addition at time t ¼ 0. We
selected an EGF dose comparable to EGFR abundance. We considered
the impact of EGF dose on recruitment by considering a significantly lower
dose and a significantly higher dose.
We caution that our simulation-based rankings of interactions are based
on the specific, technical definition of importance given previously, which
measures recruitment. With this approach, the recruitment of any one
signaling protein to EGFR is equally important regardless of the identity
of the protein. We do not attempt to account for the signaling activity of
a recruited protein, nor do we attempt to account for any dependence of
signaling activity on subcellular location, such as plasma membrane-asso-
ciated versus endosomal.RESULTS AND DISCUSSION
Development of cell line-specific models for
EGFR signaling based on KD and protein copy
number measurements
To demonstrate howproteomic data sets can be integrated and
leveraged within the formal framework of a model to rank theBiophysical Journal 108(7) 1819–1829
FIGURE 1 Interactions considered in a HeLa cell-specific version of a
model for early events in EGFR signaling. Squares at left represent sites
of EGFR autophosphorylation, squares at right represent SH2/PTB
domain-containing proteins expressed in HeLa cells, and lines connecting
squares represent interactions mapped and characterized experimentally.
The squares at right are drawn such that area is proportional to the logarithm
of measured protein copy number, and lines are drawn such that thickness is
proportional to the logarithm of 1/KD. The squares at right are ordered from
top to bottom according to predicted peak level of association with EGFR
after addition of EGF. The most highly recruited protein, SHC1, is repre-
sented at the top. To see this figure in color, go online.
1822 Stites et al.importance of protein-protein interactions, we formulated
a physicochemical, mechanistic model for early events in
EGFR signaling (see Materials and Methods section, and
Text S1, Table S1, and Software S1 in the Supporting Mate-
rial). The model was formulated for a generic/hypothetical
cell line taken to express all of the SH2/PTB domain-contain-
ing EGFR binding partners characterized in the study of
Hause et al. (5). A total of 12 cell line-specific versions of
the generic model were derived by setting protein copy
numbers on the basis of protein abundance measurements
made by Mann and co-workers for 11 mammalian cell lines
(22,36). There are twomodels for HeLa cells, one parameter-
ized on the basis of data from the study ofKulak et al. (22) and
the other parameterized on the basis of data from the study of
Geiger et al. (36). The other 10 models, which are parameter-
ized on the basis of data from the study of Geiger et al. (36),
represent EGFR signaling in HEK 293, A549, GAMG,
HepG2, Jurkat, K562, LnCap, MCF7, RKO, and U2OS cells
(36). Geiger et al. (36) did not report an EGFR copy number
for Jurkat, K562, or RKO cells, presumably because these
cells do not express EGFR. For these cells, we considered
the case of exogenous expression of EGFR at a level of
50,000 copies per cell (i.e., we set the EGFR copy number
at 50,000 per cell to mimic stable transfection of EGFR). In-
teractions considered in the models were formalized in terms
of rules (43). Rules for interactions involvingEGFRphospho-
tyrosines and SH2/PTB domain-containing binding partners
of EGFR were assigned rate constants consistent with the
KD measurements of Hause et al. (5). Use of rules allowed
us to concisely capture in our models site-specific details,
such as the phosphorylation and occupancy levels of individ-
ual SH2/PTB domain docking sites in EGFR (Fig. 1). Ac-
counting for site-specific details is difficult or impossible
when attempting to specify a model using a traditional
modeling approach (43,45,46), such as writing ODEs.
The structure of the generic model is based on mecha-
nisms considered in earlier modeling studies but is more
comprehensive in its consideration of EGFR binding part-
ners. The cell line-specific versions of the model account
for protein expression levels in various commonly used
mammalian cell lines. The parameter values of a HeLa
cell-specific version of the generic model are summarized
in Table S1; except for protein copy numbers, the other
cell line-specific models share the same parameter values.
Parameter values were set in accordance with earlier esti-
mates reported in the literature, except for protein copy
numbers and binding parameters for interactions between
phosphotyrosines in EGFR and SH2/PTB domain-contain-
ing proteins, which were set in accordance with high-
throughput proteomic data. For example, for the HeLa
cell-specific model of Table S1, copy numbers were as-
signed based on absolute protein abundance measurements
made for HeLa cells by Kulak et al. (22). Similarly, for
the HEK 293 cell-specific model, copy numbers were as-
signed based on relative protein abundance measurementsBiophysical Journal 108(7) 1819–1829made for HEK 293 cells by Geiger et al. (36). As noted
earlier, except for differences in protein copy numbers, the
cell line-specific versions of the generic model are otherwise
identical. Forward rate constants for EGFR phosphotyrosine
interactions with SH2/PTB domain-containing proteins
were all assigned a typical value for a protein-protein inter-
action. Reverse rate constants were assigned values derived
from the forward rate constant and the affinity measure-
ments of Hause et al. (5), which characterize interactions be-
tween phosphopeptides from EGFR and a set of human SH2
and PTB domains. Fig. 1 illustrates the phosphotyrosine-
SH2/PTB domain interactions considered in the HeLa cell
version of the generic model that was parameterized using
data from the study of Kulak et al. (22).Simulation of single-cell behavior
The (generic) model was formulated using BNGL, a rule-
based model-specification language (33), for the scenario
Model-Guided Analysis of Proteomic Data 1823of a single cell, and simulations were performed using the
BNGL-compatible software tools BioNetGen (33,42) and
NFsim (35), together with plain-text files that define cell-
specific versions of the generic model and corresponding
simulation protocols (Software S1). Simulations yielded
site-specific time courses of phosphorylation and recruit-
ment of signaling proteins to EGFR via their SH2/PTB
domain-mediated interactions with EGFR phosphotyro-
sines. Representative simulation results, obtained from the
HeLa cell-specific version of the model that was parameter-
ized using data from the study of Kulak et al. (22), are
shown in Fig. 2. Simulation data for all 12 cell line-specific
models considered are given in Table S2. Simulations were
performed using a stochastic method, which generates sin-
gle-cell trajectories and accounts for the stochastic nature
of chemical reaction kinetics. (We obtained population-
averaged quantities by averaging the results from multiple
simulation runs.)Noisy recruitment of signaling proteins to EGFR
Several of the time courses shown in Fig. 2 exhibit fluctu-
ations, such as those for BLK, TEC, and SHB, which have
reported abundances of 242, 424, and 859 copies per cell
(22), respectively. Noisy recruitment is even discernible
for SH2B2, which has a reported abundance of 7693 copies
per cell (22). The fluctuations reflect noisy, stochastic
recruitment of signaling proteins to EGFR because of a
combination of low copy number, low affinity, and highFIGURE 2 Heatmap summarizing predicted time courses of protein recruitm
signaling. Simulation data have been scaled such that the minimum and maximu
were obtained from a stochastic simulation of EGFR signaling in a single cell.competition. It is not clear whether intermittent recruit-
ment of signaling proteins to an activated receptor has
any physiological implications, but it is interesting to
note that the molecular circuitry of RAS-mediated control
of ERK activation, which is downstream of EGFR, has
been shown to filter transient input signals (47). This
type of filtering may be important for suppressing noise
arising from promiscuous/polyspecific interactions of sig-
naling proteins.Predicting recruitment of signaling proteins to
EGFR on the basis of affinity, abundance, and
competition
Based on physicochemical principles, we can expect that
recruitment of a signaling protein to an activated receptor
will be influenced by multiple factors. A low abundance
protein may be strongly recruited if the protein’s affinity
for the receptor is strong. Similarly, a low affinity protein
may be strongly recruited if the protein’s abundance is
high. A low affinity, low abundance protein may be strongly
recruited if it has no competition for binding to the receptor.
Thus, assessment of recruitment, which is likely a key
aspect of interaction importance, can benefit from an inte-
gration of different types of data in a model. Simulations
indicate that recruitment of signaling proteins to EGFR
indeed depends on multiple factors. As can be seen in
Fig. 3, there is a correlation between predicted recruitment
and single factors but the correlation is imperfect.ent for a HeLa cell-specific version of a model for early events in EGFR
m values for each time course are 0 and 1, respectively. The results shown
To see this figure in color, go online.
Biophysical Journal 108(7) 1819–1829
1824 Stites et al.Single factors are not expected to always be predictive of
recruitment. For example, in the middle panel of Fig. 3, it
can be seen that four proteins (RASA1, YES1, VAV2, and
PTPN11) are predicted to be more or less equally recruited
to EGFR despite having rather different copy numbers,
which range from ~26,000 copies per cell for RASA1 to
~300,000 copies per cell for PTPN11 (22). Equal levels of
recruitment are predicted for these proteins because of
compensating differences in their affinities and network
connections (Table S1). Thus, we expect that accurate rank-
ings of interaction importance will require measurements ofFIGURE 3 The predicted peak level of recruitment of a protein to EGFR
in HeLa cells correlates with the protein’s highest affinity interaction with
EGFR (top), its copy number (middle), and the number of phosphotyrosines
in EGFR with which it interacts (bottom). However, the correlations are
imperfect. The colored points correspond to SHC1 (red), GRB2 (orange),
YES1 (yellow), RASA1 (green), VAV2 (blue), and PTPN11 (purple). To
see this figure in color, go online.
Biophysical Journal 108(7) 1819–1829the multiple quantitative factors that influence interaction
strength and the integration of these measurements within
appropriate, physicochemical models. It should be noted
that single factors are not equally predictive of recruitment.
Protein copy number seems to be most predictive; network
connectivity seems to be least predictive (Fig. 3).Robustly recruited signaling proteins
According to the HeLa cell-specific model parameterized
using the data of Kulak et al. (22) (i.e., the model of Table
S1), the four signaling proteins most strongly recruited to
EGFR in HeLa cells are SHC1, GRB2, YES1, and
RASA1, as measured by peak association with EGFR after
EGF stimulation (Figs. 1 and 3). Given what we know about
EGFR signaling, it is not surprising that SHC1, GRB2, and
RASA1 should be among the most strongly recruited
proteins; however, strong recruitment of YES1 is arguably
surprising. The role of YES1 in EGFR signaling has not
been extensively studied, but available results suggest that
YES1 contributes to important processes, such as EGFR-
mediated regulation of tight junction formation (48).
YES1 has also recently been found to play a role in nuclear
translocation of EGFR, which promotes resistance to the
EGFR inhibitor cetuximab (49).
Relative levels of recruitment predicted by each of our 12
cell line-specific models are summarized in Table S3.
Notably, the results obtained from the two HeLa cell-spe-
cific models are very similar, which indicates a degree of
consistency between the characterizations of HeLa cell pro-
tein abundances reported by Geiger et al. (36) and Kulak
et al. (22). The results summarized in Table S3 collectively
indicate that five well-characterized EGFR binding partners
are robustly recruited to EGFR in multiple cell lines: SHC1,
GRB2, SRC, RASA1, and PTPN11. For 6 out of 11 cell
lines, YES1 is predicted to be more strongly recruited to
EGFR than at least one of these five proteins. However,
YES1 is predicted to be more strongly recruited than SRC
only according to the HeLa cell-specific model parameter-
ized using data from the study of Kulak et al. (22). SRC ap-
pears to be the more important Src-family member. In
several cell lines, SRC and YES1 are predicted to be co-
recruited, which suggests that these two kinases may have
nonredundant functions. YES1 may be a more important
player in EGFR signaling than is currently appreciated.Effect of EGF dose on recruitment of signaling
proteins to EGFR
Using the HeLa cell-specific model parameterized using
data from the study of Kulak et al. (22) (i.e., the model of
Table S1), we investigated the effect of EGF dose on predic-
tions of relative levels of protein recruitment. We considered
a dose of EGF 10-fold lower and 10-fold higher than the
dose used in other calculations (namely, the calculations
Model-Guided Analysis of Proteomic Data 1825of Figs. 1 and 3). The results, which are summarized in Ta-
ble S4, indicate that relative recruitment levels are insensi-
tive to EGF dose over a wide range of EGF concentrations.Differences and commonalities in recruitment
across cell lines
A notable result of our simulations is prediction of cell line-
specific differences in relative recruitment of signaling pro-
teins to EGFR. For example, PLCG1 is predicted to be an
important interaction partner of EGFR in HEK 293 cells
(Table S3) but not in HeLa cells (Figs. 1 and 3, Table S3).
Other signaling proteins that are predicted to be robustly re-
cruited to EGFR only in particular cell lines include SH2B3
in HEK 293 cells and SOCS6 in A549 cells (Table S3).
These peculiarities represent potentially testable predic-
tions. Although cell line-specific differences are predicted,
there are many commonalities. For example, according to
our simulations, SHC1 and GRB2 are among the three pro-
teins most highly recruited to EGFR in both HeLa and HEK
293 cells (Table S3). Signaling proteins that are predicted
to be robustly recruited to EGFR in multiple cell lines
include SHC1, GRB2, SRC, RASA1, YES1, and PTPN11
(Table S3).TABLE 1 Important EGFR binding partners in HeLa cells
according to each of four different metrics
Simulation Copy number (#) KD Ratio (#/KD)
SHC1 TXN SHC1 SHC1
GRB2 GRB2 SHC2 GRB2
YES1 PTPN11 PIK3R2 PTPN11
RASA1 CRKL SOCS6 PIK3R2
VAV2 CRK RASA1 YES1
PTPN11 SHC1 PIK3R3 VAV2
PIK3R2 VAV2 PLCG1 RASA1
PIK3R3 SUPT6H GRAP2 PIK3R3
SH2B2 INPPL1 SH2B3 SH2B2
PTK6 LYN YES1 PTK6
SRC YES1 SHD SRC
PIK3R1 NCK1 PIK3R1 PIK3R1
SHB RASA1 GRB2 SHB
GRB7 TNS3 LCK GRB7
BLK GRB10 PTK6 TEC
TEC TNS1 SHC4 SYK
HSH2D FER SRC BLK
VAV1 PIK3R2 SH2D1B HSH2D
The 18 proteins considered in the first column are those expressed in HeLa
cells according to Kulak et al. (22) and that also have a measured KD for at
least one EGFR phosphotyrosine, as determined in the study of Hause et al.
(5). Bold text is used to indicate proteins detected to bind EGFR (or more
precisely, to bind at least one phosphotyrosine-containing peptide derived
from EGFR) in the study of Schulze et al. (38). In each column, EGFR bind-
ing partners are ranked according to the indicated importance metric: the
simulation, copy number (#), KD or ratio (#/KD) metric. The most important
protein is listed at the top of each column. Except for the third column,
rankings are based on the protein copy measurements of Kulak et al.
(22). The rankings of the third column are based on the KD measurements
of Hause et al. (5): the ranking of a protein is determined by the minimum
KD among all interactions of the protein with phosphotyrosines in EGFR.
The protein with highest affinity is at the top.A proposed metric for ranking the relative
importance of mapped interactions in a cell
signaling network
One would like to have the ability to meaningfully rank the
mapped interactions in a cell signaling network, so that
characterization of newly discovered (or documented but
under studied) interactions can be focused productively on
the interactions most likely to have physiological relevance.
To rank the relative importance of EGFR interactions with
intracellular signaling proteins, various measures of interac-
tion importance could be considered, such as maximal or
average extent of association between binding partners
over a period of interest. Lifetime of interaction is another
potential measure of importance. Here, we consider use of
maximal extent of recruitment of a cytoplasmic protein to
EGFR after stimulation of signaling by EGF to measure
the importance of an interaction between EGFR and a bind-
ing partner. Although extent of recruitment is not neces-
sarily indicative of function, the simple colocalization of
two signaling proteins is known to have functional signifi-
cance in specific cases and is believed to be a widely used
means for achieving specificity in cell signaling networks
(50). The rankings provided in Table S3 are based on the
proposed simulation metric, i.e., this table reports relative
maximal levels of recruitment. For each of the 11 cell lines
of interest, the highly ranked proteins (according to the
simulation metric of importance) include well-characterized
players in EGFR signaling (Table S3), such as the adaptor
proteins SHC1 and GRB2.Assessment of importance rankings
To evaluate the simulation metric, we considered other
simpler metrics. In total, we considered four different met-
rics for interaction importance: the proposed metric based
on simulation results (predicted peak level of recruitment),
two single-factor metrics (protein copy number and equilib-
rium dissociation constant KD), and a metric based on the ra-
tio of copy number to KD. We assessed these metrics by
comparing predictions of interaction importance (as defined
in Materials and Methods) against measurements of EGFR
association made for HeLa (38) and HEK 293 (39) cells (Ta-
bles 1 and 2). In our analysis of the importance rankings
given in Tables 1 and 2, we asked if highly ranked interac-
tions include interactions that are detected experimentally.
Let us first consider the HeLa cell-specific association
data of Schulze et al. (38) (Table 1). The measurements
of Schulze et al. (38) identified various SH2/PTB domain-
containing binding partners for different phosphotyrosine-
containing peptides from EGFR. Five of these detected
binding partners (SHC1, GRB2, PTPN11, SRC, and CRK)
were evaluated for EGFR binding capacity in the study of
Hause et al. (5). Hause et al. (5) did not report a KD forBiophysical Journal 108(7) 1819–1829
TABLE 2 Important EGFR binding partners in HEK 293 cells
according to each of four different metrics
Simulation Copy number (#) KD Ratio (#/KD)
SHC1 TXN SHC1 SHC1
PLCG1 CRKL SHC2 GRB2
GRB2 GRB2 PIK3R2 SH2B3
SH2B3 CRK SOCS6 PLCG1
SRC PTPN11 RASA1 PTPN11
RASA1 SH2B3 PIK3R3 PIK3R2
PTPN11 SUPT6H PLCG1 RASA1
YES1 PLCG1 GRAP2 SRC
PIK3R2 NCK1 SH2B3 YES1
PIK3R3 SRC YES1 PIK3R1
VAV2 LYN SHD VAV2
PIK3R1 YES1 PIK3R1 SYK
VAV3 SHC1 GRB2 PIK3R3
SHB RASA1 LCK SLA2
TEC SYK PTK6 VAV3
The 15 proteins considered in the first column are those expressed in HEK
293 cells according to Geiger et al. (36) and that also have a measured KD
for at least one EGFR phosphotyrosine, as determined in the study of Hause
et al. (5). Bold text is used to indicate proteins detected to bind EGFR (or
more precisely, to coimmunoprecipitate with EGFR) in the study of Tong
et al. (39). It should be noted that copy numbers determined by Tong
et al. (39) were not used in our analysis. In each column, EGFR binding
partners are ranked according to the indicated importance metric: the simu-
lation, copy number (#), KD or ratio (#/KD) metric. The most important pro-
tein is listed at the top of each column. Except for the third column,
rankings are based on the protein copy measurements of Geiger et al.
(36). The rankings of the third column are based on the KD measurements
of Hause et al. (5): the ranking of a protein is determined by the minimum
KD among all interactions of the protein with phosphotyrosines in EGFR.
The protein with highest affinity is at the top.
1826 Stites et al.CRK interaction with any of the six EGFR phosphotyrosines
of interest. Thus, only the copy number metric provides a
rank for CRK. As indicated in Table 1, the simulation and
ratio metrics provide high ranks for more detected binding
partners than the other two metrics: four detected EGFR
binding partners (SHC1, GRB2, PTPN11, and SRC) are
among the top 11 in each case. Although the simulation
and ratio metrics provide similar rankings for these four
EGFR binding partners, the complete rankings produced
by the two metrics are distinct, which indicates that impor-
tance, as defined by the simulation metric, is affected by
competition. The ratio metric does not consider competi-
tion. We caution that Schulze et al. (38) did not detect all
known EGFR binding partners. Several well-established
binding partners, such as RASA1, were not detected. We
also caution that the results of Schulze et al. (38), which
are based on using bait peptides to capture SH2/PTB
domain-containing proteins from whole cell lysates, may
not perfectly reflect physiological interactions.
Let us now consider the HEK 293 cell-specific associa-
tion data of Tong et al. (39) (Table 2). Because of the
approach used in the study Tong et al. (39), the experimental
results, arguably, better reflect physiological interactions
and better correspond to predicted quantities than the
experimental results of Schulze et al. (38). Tong et al. (39)Biophysical Journal 108(7) 1819–1829detected five EGFR binding partners (SHC1, GRB2,
PLCG1, YES1, and VAV2) that contain at least one SH2
or PTB domain among the SH2/PTB domains evaluated
for EGFR binding capacity in the study of Hause et al.
(5). The simulation and ratio metrics provide similar ranks
for these EGFR binding partners: the five EGFR binding
partners are among the top 11 according to each metric.
As before (in the analysis of Table 1), the rankings provided
by the two metrics are distinct. In contrast, the copy number
and KD metrics did not provide similarly high ranks for all of
the five detected EGFR binding partners.
The simulation and ratio metrics appear to perform better
than the single-factor metrics at assigning high importance
ranks to detected EGFR binding partners (Tables 1 and 2).
The superior performance of the simulation metric suggests
that models that can account for physicochemical and
network factors influencing protein-protein interactions
(e.g., mass action and competition) may provide more use-
ful measures of interaction importance than rankings based
on copy numbers or KD’s alone. Although developing
models for cell signaling networks via traditional ap-
proaches (e.g., ODE modeling) can be problematic because
of the significant combinatorial complexity that arises when
site-specific details are considered (43,46,51–53), the rule-
based modeling approach used here is relatively straightfor-
ward. Thus, we expect that rule-based models will be
increasingly used in the future for integrating and analyzing
multiple high-throughput proteomic data sets, such as those
considered in this study.
Discrimination between the two best-performing metrics
considered here, the simulation and ratio metrics, seems not
to be possible because of the limited amount of association
data available for testing predictions of interaction impor-
tance (Tables 1 and 2). Thus, evaluation of importance
ranking approaches would benefit from generation of
more sensitive and comprehensive assays of association.
Notably, the simulation and ratio metrics produce distinct
rankings, and with new data, it could potentially be estab-
lished that one of the two metrics performs better at accu-
rately identifying interactions responsible for recruitment
of signaling proteins to EGFR. In any case, it appears that
competition, which is considered in the simulation metric
(but not in any of the simpler metrics), may influence
recruitment of signaling proteins to EGFR.CONCLUSIONS
There has been much discussion about the promise of
combining modeling and proteomics (54), but these two
fields have not so far become tightly integrated. One reason
is the difficulty of building and analyzing a model with the
scope and mechanistic detail required to connect to proteo-
mic data. Such models must encompass a larger number of
proteins and interactions than are usually considered in
models to take full advantage of proteomic data (e.g., near
Model-Guided Analysis of Proteomic Data 1827comprehensive measurements of absolute protein copy
numbers). The technical challenges of model construction
and parameterization have meant that most models devel-
oped to date only connect to a handful of biochemical
readouts. With the development of scalable, rule-based
modeling and simulation approaches, there are now exciting
opportunities to broaden the scope of our modeling efforts.
As demonstrated here, it is possible to use a mechanistic
model based on the law of mass action to integrate measure-
ments of multiple quantitative factors that influence interac-
tions among signaling proteins, allowing the combined
effects of copy number, affinity, and competition on recruit-
ment to be elucidated. We note that attempts to integrate
multiple data sets that characterize cell signaling networks,
as in the study of EGFR signaling by Waters et al. (55), typi-
cally do not involve the use a mechanistic model (i.e., a
model that synthesizes and formalizes available insights
about molecular mechanisms of signaling).
By using mechanistic, cell line-specific models to inte-
grate high-throughput KD and protein copy number mea-
surements, we were able to assess the effects of affinity,
abundance, and competition on recruitment of signaling
proteins to EGFR in particular cellular contexts. Our find-
ings include 1) the possibility of noisy recruitment, even
when an EGFR binding partner is present at thousands of
copies per cell; 2) the identification of YES1, which is not
widely viewed as an important player in EGFR signaling,
as a protein that is robustly recruited to EGFR in multiple
cell lines; and 3) the elucidation of several nonobvious
cell line-specific differences in recruitment of signaling
proteins to EGFR (e.g., strong recruitment of PLCG1
to EGFR in HEK 293 cells but not in other cell lines
considered). Moreover, we evaluated a proposed metric of
interaction importance, which labels well-known players
in EGFR signaling as important and provides rankings of
relative importance that agree well with experimental mea-
surements of association. Finally, it should be noted that
our models yield cell line-specific predictions about the ki-
netics of recruitment, which could potentially be tested
experimentally.
Although our generic model captures EGFR phosphotyr-
osine interactions with SH2/PTB domain-containing pro-
teins more comprehensively than earlier models for EGFR
signaling, we caution that this model does not represent a
comprehensive synthesis of the mechanistic knowledge
available about EGFR signaling. Indeed, parts of it represent
important processes (e.g., endocytosis) only very coarsely,
and the treatment of phosphotyrosine-SH2/PTB domain
interactions is simplified, as a matter of necessity. For
example, cooperative binding, about which little is known,
is not considered. In the future, it will be important to find
a means to consider the effects of negative and positive
binding cooperativity, which are likely at play. Negative co-
operativity can arise from steric clashes, which have been
studied computationally in the context of EGFR signalingon the basis of protein structures (56). Positive cooperativity
is known to be involved in the interaction of EGFR with
CBL, which depends on GRB2 (57,58). (It should be noted
that CBL, which recognizes phosphotyrosines using an as-
sembly of conserved domains, is not included in the models
discussed here.) It will also be important to consider other
complications, including site-specific differences in phos-
phorylation and dephosphorylation kinetics, heterodimers
of ErbB family members (which may recruit signaling pro-
teins differently than EGFR homodimers), and the effects of
subcellular location of the receptor and other signaling pro-
teins on receptor signaling.
Despite the usual uncertainties surrounding computa-
tional models of cellular regulatory systems, we are opti-
mistic that analysis of a model incorporating mechanistic
understanding and connecting to multiple proteomic data
sets, as demonstrated here, has the potential to become a
routinely applied and fairly reliable means for obtaining in-
sights into system-level behaviors that would not otherwise
be discernible.SUPPORTING MATERIAL
Supporting text, four tables, and Supporting Software are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(15)00231-3.
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